When providing technical support for a university as vast and multifaceted as UB, it is crucial for an IT department to use some form of project portfolio prioritization—a system meant to ensure that ...
Boundless Bio has announced a strategic portfolio prioritization aimed at optimizing its oncology programs, particularly focusing on the combination therapy of BBI-355 and BBI-825, alongside a new ...
Today’s health care environment is marked by transition and uncertainty. Health care managers must regularly juggle multiple project initiatives with limited time and resources, which often means ...
Highest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for meaningful value creation Company to ...
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced the prioritization of its portfolio and a 45% workforce reduction to focus resources on its Phase 2-ready ...
Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization The Company has completed enrollment of a dose ...
Aurobindo Pharma’s CuraTeQ Biologics has mutually terminated its biosimilar agreement with BioFactura for BFI-751, citing ...
GlaxoSmithKline is making headlines for its COVID-19 vaccine work, but it has quietly swept away a series of pipeline assets amid its quarterly results posted Wednesday morning. The U.S. Big Pharma is ...
Discontinuing current monotherapy and combination arms of BBI-355 in POTENTIATE clinical trial. Plans to evaluate BBI-355 and BBI-825 as a combination therapy in the POTENTIATE clinical trial, ...
Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback